Cargando…

Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis

Alcoholic hepatitis (AH) is a severe inflammatory liver disease that develops in some heavy drinkers. The immune system in patients with AH is hyperactive and yet dysfunctional. Here, we investigated whether this immune‐dysregulated state is related to the alcoholic impact on immune checkpoints (ICP...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Xia, Ying, Yang, Jing, Guo, Haitao, Sun, Guoqing, Sanyal, Arun J., Shah, Vijay H., Lou, Yongliang, Zheng, Xiaoqun, Chalasani, Naga, Yu, Qigui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109345/
https://www.ncbi.nlm.nih.gov/pubmed/32258953
http://dx.doi.org/10.1002/hep4.1475
_version_ 1783512936876081152
author Li, Wei
Xia, Ying
Yang, Jing
Guo, Haitao
Sun, Guoqing
Sanyal, Arun J.
Shah, Vijay H.
Lou, Yongliang
Zheng, Xiaoqun
Chalasani, Naga
Yu, Qigui
author_facet Li, Wei
Xia, Ying
Yang, Jing
Guo, Haitao
Sun, Guoqing
Sanyal, Arun J.
Shah, Vijay H.
Lou, Yongliang
Zheng, Xiaoqun
Chalasani, Naga
Yu, Qigui
author_sort Li, Wei
collection PubMed
description Alcoholic hepatitis (AH) is a severe inflammatory liver disease that develops in some heavy drinkers. The immune system in patients with AH is hyperactive and yet dysfunctional. Here, we investigated whether this immune‐dysregulated state is related to the alcoholic impact on immune checkpoints (ICPs). We used multiplex immunoassays and enzyme‐linked immunosorbent assay to quantify plasma levels of 18 soluble ICPs (sICPs) from 81 patients with AH, 65 heavy drinkers without liver diseases (HDCs), and 39 healthy controls (HCs) at baseline, 33 patients with AH and 32 HDCs at 6‐month follow‐up, and 18 patients with AH and 29 HDCs at 12‐month follow‐up. We demonstrated that baseline levels of 6 sICPs (soluble T‐cell immunoglobulin and mucin domain 3 [sTIM‐3], soluble cluster of differentiation [sCD]27, sCD40, soluble Toll‐like receptor‐2 [sTLR‐2], soluble herpesvirus entry mediator [sHVEM], and soluble lymphotoxin‐like inducible protein that competes with glycoprotein D for herpes virus entry on T cells [sLIGHT]) were up‐regulated, while 11 sICPs (soluble B‐ and T‐lymphocyte attenuator [sBTLA], sCD160, soluble cytotoxic T‐lymphocyte‐associated protein 4 [sCTLA‐4], soluble lymphocyte‐activation gene 3 [sLAG‐3], soluble programmed death 1 [sPD‐1], sPD ligand 1 [sPD‐L1], sCD28, soluble glucocorticoid‐induced tumor necrosis factor receptor‐related protein [sGITR], sGITR ligand [sGITRL], sCD80, and inducible T‐cell costimulator [sICOS]) were down‐regulated in patients with AH compared to HDCs. The up‐regulated sICPs except sLIGHT and down‐regulated sCD80, sCD160, sCTLA‐4, and sLAG‐3 correlated positively or negatively with AH disease severity, bacterial translocation, and inflammatory factors. At follow‐up, abstinent patients with AH still had higher levels of several sICPs compared to HDCs. We also compared expression of 10 membrane‐bound ICPs (mICPs) on peripheral blood mononuclear cells (PBMCs) from patients with AH and HCs by flow cytometry and found that several mICPs were dysregulated on blood cells from patients with AH. The function and regulation of sICPs and mICPs were studied using PBMCs from patients with AH and HCs. Recombinant sHVEM affected tumor necrosis factor (TNF)‐α and interferon‐γ production by T cells from patients with AH and HCs. Conclusion: Both sICPs and mICPs were dysregulated in patients with AH, and alcohol abstinence did not fully reverse these abnormalities. The HVEM axis plays a role in regulating T‐cell function in patients with AH.
format Online
Article
Text
id pubmed-7109345
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71093452020-04-01 Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis Li, Wei Xia, Ying Yang, Jing Guo, Haitao Sun, Guoqing Sanyal, Arun J. Shah, Vijay H. Lou, Yongliang Zheng, Xiaoqun Chalasani, Naga Yu, Qigui Hepatol Commun Original Articles Alcoholic hepatitis (AH) is a severe inflammatory liver disease that develops in some heavy drinkers. The immune system in patients with AH is hyperactive and yet dysfunctional. Here, we investigated whether this immune‐dysregulated state is related to the alcoholic impact on immune checkpoints (ICPs). We used multiplex immunoassays and enzyme‐linked immunosorbent assay to quantify plasma levels of 18 soluble ICPs (sICPs) from 81 patients with AH, 65 heavy drinkers without liver diseases (HDCs), and 39 healthy controls (HCs) at baseline, 33 patients with AH and 32 HDCs at 6‐month follow‐up, and 18 patients with AH and 29 HDCs at 12‐month follow‐up. We demonstrated that baseline levels of 6 sICPs (soluble T‐cell immunoglobulin and mucin domain 3 [sTIM‐3], soluble cluster of differentiation [sCD]27, sCD40, soluble Toll‐like receptor‐2 [sTLR‐2], soluble herpesvirus entry mediator [sHVEM], and soluble lymphotoxin‐like inducible protein that competes with glycoprotein D for herpes virus entry on T cells [sLIGHT]) were up‐regulated, while 11 sICPs (soluble B‐ and T‐lymphocyte attenuator [sBTLA], sCD160, soluble cytotoxic T‐lymphocyte‐associated protein 4 [sCTLA‐4], soluble lymphocyte‐activation gene 3 [sLAG‐3], soluble programmed death 1 [sPD‐1], sPD ligand 1 [sPD‐L1], sCD28, soluble glucocorticoid‐induced tumor necrosis factor receptor‐related protein [sGITR], sGITR ligand [sGITRL], sCD80, and inducible T‐cell costimulator [sICOS]) were down‐regulated in patients with AH compared to HDCs. The up‐regulated sICPs except sLIGHT and down‐regulated sCD80, sCD160, sCTLA‐4, and sLAG‐3 correlated positively or negatively with AH disease severity, bacterial translocation, and inflammatory factors. At follow‐up, abstinent patients with AH still had higher levels of several sICPs compared to HDCs. We also compared expression of 10 membrane‐bound ICPs (mICPs) on peripheral blood mononuclear cells (PBMCs) from patients with AH and HCs by flow cytometry and found that several mICPs were dysregulated on blood cells from patients with AH. The function and regulation of sICPs and mICPs were studied using PBMCs from patients with AH and HCs. Recombinant sHVEM affected tumor necrosis factor (TNF)‐α and interferon‐γ production by T cells from patients with AH and HCs. Conclusion: Both sICPs and mICPs were dysregulated in patients with AH, and alcohol abstinence did not fully reverse these abnormalities. The HVEM axis plays a role in regulating T‐cell function in patients with AH. John Wiley and Sons Inc. 2020-01-12 /pmc/articles/PMC7109345/ /pubmed/32258953 http://dx.doi.org/10.1002/hep4.1475 Text en © 2020 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Li, Wei
Xia, Ying
Yang, Jing
Guo, Haitao
Sun, Guoqing
Sanyal, Arun J.
Shah, Vijay H.
Lou, Yongliang
Zheng, Xiaoqun
Chalasani, Naga
Yu, Qigui
Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis
title Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis
title_full Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis
title_fullStr Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis
title_full_unstemmed Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis
title_short Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis
title_sort immune checkpoint axes are dysregulated in patients with alcoholic hepatitis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109345/
https://www.ncbi.nlm.nih.gov/pubmed/32258953
http://dx.doi.org/10.1002/hep4.1475
work_keys_str_mv AT liwei immunecheckpointaxesaredysregulatedinpatientswithalcoholichepatitis
AT xiaying immunecheckpointaxesaredysregulatedinpatientswithalcoholichepatitis
AT yangjing immunecheckpointaxesaredysregulatedinpatientswithalcoholichepatitis
AT guohaitao immunecheckpointaxesaredysregulatedinpatientswithalcoholichepatitis
AT sunguoqing immunecheckpointaxesaredysregulatedinpatientswithalcoholichepatitis
AT sanyalarunj immunecheckpointaxesaredysregulatedinpatientswithalcoholichepatitis
AT shahvijayh immunecheckpointaxesaredysregulatedinpatientswithalcoholichepatitis
AT louyongliang immunecheckpointaxesaredysregulatedinpatientswithalcoholichepatitis
AT zhengxiaoqun immunecheckpointaxesaredysregulatedinpatientswithalcoholichepatitis
AT chalasaninaga immunecheckpointaxesaredysregulatedinpatientswithalcoholichepatitis
AT yuqigui immunecheckpointaxesaredysregulatedinpatientswithalcoholichepatitis